Here's the gist, there are a few figures and further explanation in the announcement.
MMJ PhytoTech Limited (ASX:MMJ) (the “Company”) are pleased to announce that on 11 February 2016 the Company’s Israeli subsidiary, Phytotech Therapeutics Ltd, received very successful results from its Phase 1 clinical trial (Trial) being undertaken on two medicinal cannabis (MC) oral capsule formulations licensed exclusively from Yissum, the commercialisation arm of the Hebrew University of Jerusalem.
Phase 1 Clinical Trial Results
The results of the Trials are extremely positive with consistent results among all 14 completers (14/15 initiating test subjects).
The Trial yielded the following promising results;
- Demonstrable safety and tolerability profile with no significant side effects;
- Higher bioavailability of active compounds in comparison to GW Pharmaceuticals
oromucosal spray – Sativex;
- Very rapid onset; and
- 8 hours exposure time in the blood.
- Forums
- ASX - By Stock
- HGV
- Ann: Successful Results of Phase 1 Clinical Trial
Ann: Successful Results of Phase 1 Clinical Trial, page-4
-
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HGV (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.412M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 4.0¢ | $1.402K | 35.05K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 366715 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 366715 | 0.040 |
2 | 215461 | 0.039 |
1 | 135135 | 0.035 |
1 | 40000 | 0.034 |
1 | 30303 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 10000 | 1 |
0.045 | 60000 | 1 |
0.047 | 20000 | 1 |
0.049 | 130000 | 2 |
0.050 | 52267 | 2 |
Last trade - 15.54pm 13/09/2024 (20 minute delay) ? |
Featured News
HGV (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online